Millennium Management’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,851,473
| Closed | -$18.4M | – | 7126 |
|
|
2023
Q1 | $18.4M | Buy |
1,851,473
+1,411,560
| +321% | +$14M | 0.01% | 1397 |
|
|
2022
Q4 | $4.39M | Buy |
439,913
+388,982
| +764% | +$2.9M | ﹤0.01% | 2926 |
|
|
2022
Q3 | $281K | Sell |
50,931
-25,301
| -33% | -$140K | ﹤0.01% | 5436 |
|
|
2022
Q2 | $278K | Sell |
76,232
-20,907
| -22% | -$98.8K | ﹤0.01% | 5431 |
|
|
2022
Q1 | $588K | Sell |
97,139
-37,393
| -28% | -$228K | ﹤0.01% | 5002 |
|
|
2021
Q4 | $1.13M | Buy |
+134,532
| New | +$1.18M | ﹤0.01% | 4299 |
|
|
2021
Q3 | – | Sell |
-35,648
| Closed | -$289K | – | 7446 |
|
|
2021
Q2 | $289K | Sell |
35,648
-25,097
| -41% | -$172K | ﹤0.01% | 5758 |
|
|
2021
Q1 | $335K | Buy |
+60,745
| New | +$300K | ﹤0.01% | 5139 |
|
|
2019
Q2 | – | Sell |
-12,081
| Closed | -$45K | – | 4616 |
|
|
2019
Q1 | $45K | Buy |
12,081
+300
| +3% | +$1.05K | ﹤0.01% | 3903 |
|
|
2018
Q4 | $41K | Buy |
+11,781
| New | +$58.2K | ﹤0.01% | 3631 |
|
|
2017
Q4 | – | Sell |
-11,589
| Closed | -$54K | – | 4177 |
|
|
2017
Q3 | $54K | Buy |
+11,589
| New | +$61.2K | ﹤0.01% | 3404 |
|
Millennium Management's APEN Position: Q2 2023 in Review
Millennium Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 1,851,473 shares — an estimated $18.4M sold.
Millennium Management first reported a position in APEN in Q3 2017 and held it in 11 quarters. The position peaked at $18.4M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Millennium Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Millennium Management sold 1,851,473 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $18.4M.
- Millennium Management first reported a position in Apollo Endosurgery, Inc. in Q3 2017 and held it in 11 quarters.
- Millennium Management's Apollo Endosurgery, Inc. position peaked at $18.4M in Q1 2023.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.